Deutsche Bank assumed coverage on shares of Colgate-Palmolive (NYSE:CL) in a research report sent to investors on Wednesday, Marketbeat reports. The brokerage issued a hold rating and a $75.00 price target on the stock.

Several other research firms also recently commented on CL. Zacks Investment Research downgraded Colgate-Palmolive from a buy rating to a hold rating in a research report on Tuesday, October 17th. KeyCorp reissued a hold rating on shares of Colgate-Palmolive in a research report on Monday, October 16th. SunTrust Banks raised Colgate-Palmolive from a hold rating to a buy rating and increased their price target for the stock from $65.00 to $85.00 in a research report on Wednesday, October 11th. Societe Generale downgraded Colgate-Palmolive from a hold rating to a sell rating and set a $66.00 price target on the stock. in a research report on Wednesday, November 29th. They noted that the move was a valuation call. Finally, Royal Bank of Canada reissued a hold rating and set a $74.00 price target on shares of Colgate-Palmolive in a research report on Sunday, October 8th. Two investment analysts have rated the stock with a sell rating, fifteen have given a hold rating and four have issued a buy rating to the stock. Colgate-Palmolive has a consensus rating of Hold and an average target price of $76.04.

Colgate-Palmolive (NYSE CL) opened at $74.05 on Wednesday. Colgate-Palmolive has a 12-month low of $63.43 and a 12-month high of $77.27. The company has a debt-to-equity ratio of 24.42, a current ratio of 1.23 and a quick ratio of 0.92. The company has a market capitalization of $65,023.68, a P/E ratio of 25.80, a PEG ratio of 3.39 and a beta of 0.81.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, October 27th. The company reported $0.73 EPS for the quarter, meeting the consensus estimate of $0.73. Colgate-Palmolive had a return on equity of 2,782.56% and a net margin of 15.10%. The company had revenue of $3.97 billion for the quarter, compared to the consensus estimate of $3.94 billion. During the same quarter in the prior year, the business earned $0.73 earnings per share. The firm’s revenue for the quarter was up 2.8% on a year-over-year basis. sell-side analysts expect that Colgate-Palmolive will post 2.88 EPS for the current fiscal year.

In other Colgate-Palmolive news, COO Justin Skala sold 126,393 shares of the firm’s stock in a transaction on Thursday, November 9th. The stock was sold at an average price of $72.97, for a total value of $9,222,897.21. Following the sale, the chief operating officer now owns 262,361 shares of the company’s stock, valued at approximately $19,144,482.17. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Stephen I. Sadove sold 20,780 shares of the firm’s stock in a transaction on Monday, November 6th. The shares were sold at an average price of $70.52, for a total value of $1,465,405.60. Following the completion of the sale, the director now directly owns 36,268 shares in the company, valued at approximately $2,557,619.36. The disclosure for this sale can be found here. In the last ninety days, insiders sold 181,048 shares of company stock worth $13,168,995. Company insiders own 1.02% of the company’s stock.

Several hedge funds have recently modified their holdings of the business. Proficio Capital Partners LLC lifted its stake in shares of Colgate-Palmolive by 16.9% in the 1st quarter. Proficio Capital Partners LLC now owns 1,432 shares of the company’s stock valued at $107,000 after acquiring an additional 207 shares during the last quarter. Jacobi Capital Management LLC lifted its stake in shares of Colgate-Palmolive by 125.5% in the 3rd quarter. Jacobi Capital Management LLC now owns 1,443 shares of the company’s stock valued at $104,000 after acquiring an additional 803 shares during the last quarter. OLD Second National Bank of Aurora bought a new position in shares of Colgate-Palmolive in the 2nd quarter valued at $109,000. Krilogy Financial LLC lifted its stake in shares of Colgate-Palmolive by 23.0% in the 2nd quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock valued at $115,000 after acquiring an additional 289 shares during the last quarter. Finally, Hanson & Doremus Investment Management lifted its stake in shares of Colgate-Palmolive by 4.5% in the 2nd quarter. Hanson & Doremus Investment Management now owns 1,630 shares of the company’s stock valued at $121,000 after acquiring an additional 70 shares during the last quarter. 72.96% of the stock is currently owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION WARNING: This piece was originally posted by Watch List News and is the sole property of of Watch List News. If you are reading this piece on another website, it was illegally copied and reposted in violation of US & international copyright laws. The legal version of this piece can be read at https://www.watchlistnews.com/colgate-palmolive-cl-coverage-initiated-at-deutsche-bank/1769401.html.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Analyst Recommendations for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with Analyst Ratings Network's FREE daily email newsletter.